Literature DB >> 11772479

Voucher-based reinforcement of opiate abstinence during methadone detoxification.

Elias Robles1, Maxine L Stitzer, Eric C Strain, George E Bigelow, Kenneth Silverman.   

Abstract

Methadone detoxification is often used in the treatment of opiate dependence. This procedure, however, is frequently associated with continued opiate use, and high rates of attrition and relapse. In this study, a 90-day methadone detoxification was enhanced by adding voucher-based reinforcement of opiate abstinence before, during and after the dose tapering schedule. After 4 weeks of standard methadone maintenance (baseline), subjects were randomized to either the abstinence (n=26), or attendance reinforcement (n=22) condition. During the remaining 22 weeks of the study, the abstinence reinforcement group could receive vouchers with monetary value three times per week for providing opiate-negative urine specimens, while subjects in the attendance reinforcement group received vouchers of equal value for attending the clinic, regardless of urinalysis results. Methadone maintenance continued during weeks 5-10, dose tapering was implemented during weeks 11-23, and during weeks 24-26 the voucher schedule remained in effect but no medication was provided. Fifty percent of clients in both groups completed dose tapering, and 40% completed the vouchers-only phase. Subjects in the abstinence as compared with the attendance reinforcement group had lower rates of opiate use during the maintenance and detoxification phases, and longer periods of opiate abstinence during the detoxification phase. Cocaine use was also lower in the abstinence than the attendance reinforcement group during the maintenance and detoxification phases. In addition, abstinence as compared with attendance reinforcement subjects reported significantly fewer intravenous injections during the detoxification phase. Voucher-based reinforcement procedures could be useful for successfully transitioning patients into opiate antagonist therapy, or drug-free treatments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11772479     DOI: 10.1016/s0376-8716(01)00160-0

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  16 in total

1.  Using Acceptance and Commitment Therapy during Methadone Dose Reduction: Rationale, Treatment Description, and a Case Report.

Authors:  Angela L Stotts; Akihiko Masuda; Kelly Wilson
Journal:  Cogn Behav Pract       Date:  2009-05-01

2.  Contingency Management Abstinence Incentives: Cost and Implications for Treatment Tailoring.

Authors:  Colin Cunningham; Maxine Stitzer; Aimee N C Campbell; Martina Pavlicova; Mei-Chen Hu; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2015-09-21

3.  The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial.

Authors:  Brantley P Jarvis; August F Holtyn; Anthony DeFulio; Mikhail N Koffarnus; Jeannie-Marie S Leoutsakos; Annie Umbricht; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Journal:  Drug Alcohol Depend       Date:  2019-02-14       Impact factor: 4.492

4.  Contingency management intervention targeting co-addiction of alcohol and drugs among American Indian adults: Design, methodology, and baseline data.

Authors:  Ekaterina Burduli; Jordan Skalisky; Katherine Hirchak; Michael F Orr; Albert Foote; Alexandria Granbois; Richard Ries; John M Roll; Dedra Buchwald; Michael G McDonell; Sterling M McPherson
Journal:  Clin Trials       Date:  2018-08-29       Impact factor: 2.486

5.  Pilot investigation: randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management.

Authors:  Michael F Orr; Crystal Lederhos Smith; Myles Finlay; Samantha C Martin; Olivia Brooks; Oladunni A Oluwoye; Emily Leickly; Michael McDonell; Ekaterina Burduli; Celestina Barbosa-Leiker; Matt Layton; John M Roll; Sterling M McPherson
Journal:  Behav Pharmacol       Date:  2018-08       Impact factor: 2.293

6.  Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.

Authors:  Brantley P Jarvis; August F Holtyn; Anthony DeFulio; Kelly E Dunn; Jeffrey J Everly; Jeannie-Marie S Leoutsakos; Annie Umbricht; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Journal:  Addiction       Date:  2017-02-03       Impact factor: 6.526

7.  Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial.

Authors:  Anthony DeFulio; Jeffrey J Everly; Jeannie-Marie S Leoutsakos; Annie Umbricht; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Journal:  Drug Alcohol Depend       Date:  2011-07-22       Impact factor: 4.492

8.  Duration effects in contingency management treatment of methamphetamine disorders.

Authors:  John M Roll; Joy Chudzynski; Jennifer M Cameron; Donelle N Howell; Sterling McPherson
Journal:  Addict Behav       Date:  2013-04-03       Impact factor: 3.913

9.  Examining Longitudinal Stimulant Use and Treatment Attendance as Parallel Outcomes in Two Contingency Management Randomized Clinical Trials.

Authors:  Sterling McPherson; Olivia Brooks; Celestina Barbosa-Leiker; Crystal Lederhos; Amanda Lamp; Sean Murphy; Matthew Layton; John Roll
Journal:  J Subst Abuse Treat       Date:  2015-09-21

10.  The Utility of Operant Conditioning to Address Poverty and Drug Addiction.

Authors:  Kenneth Silverman; August F Holtyn; Forrest Toegel
Journal:  Perspect Behav Sci       Date:  2019-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.